Loading clinical trials...
Loading clinical trials...
This is the second phase of a two-part study. In the first phase (Protocol ID: R34AT009170), the investigators refined and piloted the Relaxation Response Resiliency (3RP) intervention for women age 5...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Massachusetts General Hospital
Collaborators
NCT07474363 · Major Depressive Disorder (MDD), Gender Differences, and more
NCT06771167 · Resilience, Psychological, Burnout, Psychological, and more
NCT05094115 · Resilience, Psychological, Stress, Physiological
NCT07087886 · Resilience, Psychological
NCT06077097 · Chronic Pain, Adverse Childhood Experiences, and more
Massachusetts General Hospital
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions